Penumbra, Inc. to Present at the Jefferies London Healthcare Conference
Get Alerts PEN Hot Sheet
Join SI Premium – FREE
ALAMEDA, Calif., Nov. 1, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Jefferies London Healthcare Conference on Tuesday, November 15, 2022.
Event: | Jefferies London Healthcare Conference |
Date: | Tuesday, November 15, 2022 |
Time: | 9:10am GMT / 1:10am PT |
An audio webcast of the presentation will be available by visiting the investors' section of the company's website at www.penumbrainc.com. The audio webcast will be available on the company's website for at least two weeks following the event.
About Penumbra Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.
Investor Relations
Penumbra, Inc.510-995-2461
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-jefferies-london-healthcare-conference-301662701.html
SOURCE Penumbra, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SCHEELS Opens 35th Location to Massive Crowds in Cedar Park, Texas
- Matthew Syken, Los Angeles, CA Attorney, Opens Scholarship Opportunity for Future Legal Leaders
- Women Leaders Association Adds Lisa Reilly as Boston Coaching Partner, Bringing 23 Years of Biotech Leadership and Her Reclamation Method to High-Achieving Women
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Jefferies & Co, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share